Star Combo Pharma Ltd.ASX: S66

S66 2026 ASX Appendix 4G

· Issued by Star Combo Pharma Ltd. via ASX

Filed with ASX ·

Rules 4.7.3 and 4.10.3 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity: ABN / ARBN: Financial year ended: Star Combo Pharma Limited 38 615 728 375 30 June 2026 2 3 Our corporate governance statement for the above period above can be found...

View Attachment

6ix hasn’t read this filing yet.

Star Combo Pharma Ltd. on 6ix

Earlier from Star Combo Pharma

All Star Combo Pharma news releases